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Abstract 
Water can pass through the cell membrane relatively slowly by diffusion. However, in order 
to maintain water homeostasis, the rapid and specific regulation of cellular water flow is 
mediated by the aquaporin (AQP) family of membrane protein water channels. Thirteen 
human AQPs have been identified to date and the majority are highly specific for water while 
others show selectivity for water, glycerol and other small solutes. The wide range of tissues 
that are known to express AQPs is reflected by their involvement in many physiological 
processes and diseases. Receptor mediated translocation, via hormone activation, is an 
established method of AQP regulation, especially for AQP2. There is now an emerging 
consensus that the rapid and reversible translocation of other AQPs from intracellular vesicles 
to the plasma membrane, triggered by a range of stimuli, can confer increased membrane 
permeability. This review examines new advances that have identified molecular mechanisms 
of AQP regulation; these include the role of cytoskeletal proteins, kinases, calcium and 
retention or localisation signals as well as specific triggers of AQP translocation. This article 
reviews current knowledge of AQP regulation with a focus on rapid and dynamic regulation 
of sub-cellular AQP translocation in response to a specific trigger.  
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Introduction 
Over 50% of total body water content is found inside cells. The water content of different 
tissues is diverse and ranges from about 10% in adipocytes to 75% in muscle tissue (Martini, 
2009). Consequently, the homeostasis of the intracellular fluid (the cytosol) and the 
extracellular fluid (the interstitial fluid, plasma and other body fluids) is physiologically 
essential (Martini, 2009). In order to maintain this physiological homeostasis, the control of 
cellular water flow must be tightly regulated. In mammals, water can pass into and out of cells 
by diffusion through the plasma membrane and may also be co-transported passively with 
other ions or solutes (Loo et al., 1996). Neither of these routes permits the rapid, regulated 
and selective water permeability that is evident in tissues such as kidney and secretory glands. 
Rather, cellular water flow is mediated by aquaporin water channels (AQPs), which were first 
discovered in 1993 (Agre et al., 1993). Since then, 13 members of this membrane protein 
family have been identified in humans (AQP0-12), which are distributed throughout a wide 
range of tissues. For example, AQP1 has been shown to be highly expressed in red blood 
cells, kidney proximal tubule cells and many other tissues (Magni et al., 2006), while AQP11 
has been found at low levels in smooth muscle or cells of the immune system (Ishibashi, 
2009). A number of studies have also shown that AQPs play a role in various disorders from 
renal disease to cerebral oedema (Benarroch, 2007, Schrier and Cadnapaphornchai, 2003) and 
even cancer (Yin et al., 2008, Chae et al., 2008). Consequently AQPs have been highlighted 
as key drug targets (Huber et al., 2012, Wang et al., 2006) although drugs that target AQPs for 
clinical use remain to be discovered. This diverse tissue distribution and involvement in many 
physiological and pathological processes, is summarised in Table 1.  
Structure and function of AQPs 
The high resolution structures of several AQPs have been resolved (see Tornroth-Horsefield 
et al., 2010 for review) and these include the structures of human AQP1, 4 and 5 (Murata et 
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al., 2000, Ho et al., 2009, Horsefield et al., 2008). (Harries et al., 2004, Ho et al., 2009, 
Horsefield et al., 2008, Murata et al., 2000) revealing that the family shares a conserved 
architecture (Figure 1). AQPs exist as homotetramers with four AQP subunits per functional 
AQP tetramer; selective transport of water molecules, glycerol and/or ions occurs through 
each of the four pores. The carboxyl and amino termini of an AQP monomer is orientated 
towards the cytoplasm with six transmembrane α-helices linked by alternating extracellular 
and intracellular loops (designated A-E). The six α-helices are arranged in a right-handed 
bundle forming the highly water selective central pore, which resembles an hour-glass 
(Scheuring et al., 2000).  
 
The pore of mammalian AQPs is widely acknowledged to be constitutively open and highly 
specific (Walz et al., 2009). Pore specificity involves two selection stages (de Groot and 
Grubmuller, 2001); the first is due to the fact that intracellular loop B and extracellular loop E 
fold into the transmembrane pore, each forming a helical region containing a highly 
conserved Asn-Pro-Ala (NPA) motif. Consequently, passage of the majority of ions, such as 
Na+ is prohibited (Wu et al., 2009). The second stage is due to the aromatic/arginine (ar/R) 
constriction site region and facilitates water selectivity through re-positioning of water 
molecules and the exclusion of protons (de Groot et al., 2001).  
 
AQPs 0, 1, 2, 4, 5 and 8 are thought to be permeable only to water, whilst AQPs 3, 7, 9 and 
10 are known as aquaglyceroporins because they are permeable to both water and small non-
ionic molecules such as glycerol, urea and ammonia (de Groot et al., 2003b, de Groot and 
Grubmuller, 2001, Litman et al., 2009). AQP6 is highly specific for water but may also be 
permeable to ionic molecules (Beitz et al., 2006). AQPs 11 and 12 are thought to function as 
water channels but have yet to be fully characterised  (Ishibashi, 2009). Notably, the sequence 
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of the NPA motifs within AQP11 and 12 deviates from the conserved NPA of the other AQPs 
(Ikeda et al., 2010, Itoh et al., 2005). 
 
It is clear that the structural features of the AQP family and the mechanism of selective water 
passage through the AQP pore are now established (de Groot et al., 2003a, de Groot and 
Grubmuller, 2001). However, less information is available describing how AQPs regulate the 
flow of water into and out of cells in order to meet the constant and rapid changes in local 
cellular environment that challenge them.  
 
What regulates AQP function? 
Eukaryotes have evolved to fine-tune water transport through AQPs by three main regulatory 
mechanisms: (i) at the transcriptional/translational level (Matsumura et al., 1997); (ii) by 
conformational change or “gating” (Walz et al., 2009); and (iii) by translocation to the 
membrane in response to a trigger (Nedvetsky et al., 2009). Regulation by AQP gene 
expression can be achieved over a timescale fromminutes to days (Gunnarson et al., 2004, 
Zelenina, 2010). However, a gene expression model for regulation of membrane permeability 
is contingent upon constitutive membrane expression, which does not account for the 
established receptor-mediated regulation of AQP2 sub-cellular localisation (Nedvetsky et al., 
2009) or the dynamic control of AQPs that may be necessary to rapidly alter membrane water 
permeability. 
 
Water permeability through the AQP pore can be inhibited by non-specific, usually mercury-
based compounds (Savage and Stroud, 2007). Alterations in pH and calcium concentration, 
through interaction with specific histidine residues within the AQP pore have also been 
shown to cause different effects on water permeability in bovine and fish AQPs, despite 
6 
 
sharing approximately 70% of their sequence (Nemeth-Cahalan et al., 2004). Regulation via 
gating mechanisms, which allow conformationally distinct open and closed states, has 
specifically been reported for plant and microbial AQPs (Tornroth-Horsefield et al., 2006). 
Structures of gated AQPs have revealed the molecular details of gating by phosphorylation, 
pH and Ca2+ for the spinach aquaporin, SoPIP2;1 (Johansson et al., 1996), and 
mechanosensivity for the yeast aquaporin, AQY1 (Fischer et al., 2009). Direct 
phosphorylation has also been suggested to cause an increase in water permeability of AQP1 
(Han and Patil, 2000), whereas the water permeability of phosphorylated AQP5 has been 
suggested to be indistinguishable from that of non-phosphorylated AQP5 (Sidhaye et al., 
2005, Woo et al., 2008). The role of gating in the regulation of mammalian AQP function 
therefore remains to be conclusively established, but it is not a widely-accepted regulatory 
mechanism for water homeostasis in mammalian AQPs (Wang and Tajkhorshid, 2007).  
 
In contrast to regulation by AQP gene expression, and in the absence of an established gating 
mechanism, a more dynamic, rapid and selective means of regulation could be achieved by 
translocation of AQPs: the regulation of membrane permeability is possible by altering AQP 
abundance in response to a specific trigger. Tables 2 and 3 summarise current knowledge of 
triggers and mechanisms of post-translational AQP translocation. It is possible that the 
regulation of basal membrane expression following translation and Golgi processing of 
nascent AQP proteins shares mechanisms with such post-translational, induced subcellular 
localisation. 
 
What triggers AQP translocation? 
The most well established trigger of post-translational AQP translocation is the G protein-
coupled receptor (GPCR) agonist, vasopressin, which induces translocation of AQP2 to 
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promote water reabsorption in the kidney (Table 2). AQP2 is retained in sub-cellular 
compartments and translocation occurs as a result of vasopressin binding and activating the 
vasopressin V2 GPCR. Subsequently, the G protein, Gs, initiates adenylate cyclase activation 
leading to increases in cyclic AMP which mediates activation of protein kinase A (PKA) and 
results in phosphorylation of serine 256 on the C-terminus of AQP2. This facilitates AQP2 
translocation to the plasma membrane and water reabsorption in order to maintain osmotic 
homeostasis (see (Valenti et al., 2005) for review).  
 
A number of other GPCR agonists are also thought to regulate AQP translocation events 
(Table 2). For example, early studies demonstrated that secretin, a hormone involved in 
osmoregulation, promotes osmotic water movement in cholangiocytes by inducing exocytic 
insertion of AQP1 into the cell membrane (Marinelli et al., 1997). Quantitative 
immunoblotting assays revealed an inverse correlation between the presence of AQP1 at the 
plasma membrane and within the microsomal intracellular compartment in response to 
secretin. In the case of AQP3, the beta-adrenergic receptor agonist, isoprenaline, and the 
adrenergic receptor agonist, adrenaline, have been shown to trigger its translocation in human 
adipocytes and Caco-2 cells, respectively (Rodriguez et al., 2011b, Yasui et al., 2008). A 
decrease in cell water permeability was discovered to be linked to the internalisation of AQP4 
from the cell surface following histamine stimulation (Carmosino et al., 2007). Recently, it 
was determined that short term regulation of AQP4 is also mediated by vasopressin; (Moeller 
et al., 2009) in the presence of vasopressin, a reduction in water permeability was detected. 
The water permeability of astrocytes has also been shown to be affected by glutamate 
activation of metabotropic glutamate receptors that may mediate AQP4 translocation 
(Gunnarson et al., 2008). Understanding how induced translocation affects water permeability 
of a cell is also likely to be crucial in physiological processes such as maintenance of the 
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blood brain barrier (Saadoun and Papadopoulos, 2009). Furthermore, the membrane-
localisation of AQP4 in astrocytes is a physiological requirement for the formation of 
cytotoxic brain oedema following stroke, blunt-force trauma or meningitis (Papadopoulos and 
Verkman, 2007). Finally, AQP5, which has a major role in the generation of saliva, tears and 
pulmonary secretions, has been shown to translocate to the plasma membrane of rat parotid 
cells upon stimulation with the M3 muscarinic GPCR agonist, acetylcholine, or the adrenergic 
receptor agonist, adrenaline (Ishikawa et al., 1999). Internalisation of AQP5 was observed 
following prolonged exposure to acetylcholine (Ishikawa et al., 1998a, Ishikawa et al., 2002). 
A 4 h stimulation with the agonist, isoprenaline, was also shown to mediate the translocation 
of AQP7 from the cytoplasm compartment to the plasma membrane (Rodriguez et al., 2011b). 
Vasoactive intestinal polypeptide and lipopolysacharide has been shown to trigger the 
translocation of AQP5 to the plasma membrane of duodenal Brunner's gland cells (Parvin et 
al., 2005) and mouse lung epithelial cells (Ohinata et al., 2005), respectively. 
 
As AQPs are water channels, it is not surprising that water itself might act as a trigger for 
AQP translocation: a recent study described how immunofluorescent staining revealed 
cytoplasmic localisation of AQP3 and its translocation to the cell membrane of cultured, 
human keratinocytes following a 2 h osmotic stress (Garcia et al., 2011). Hypertonicity has 
also been shown to trigger the translocation of AQPs 1, 2, 3, 4, 5 and 9 (Arima et al., 2003, 
Hasler et al., 2005, Hoffert et al., 2000, Loitto et al., 2007, Matsuzaki et al., 2001) whilst 
hypotonicity has been shown to be involved in translocation of AQPs 1, 3 and 8 (Conner et 
al., 2012, Conner et al., 2010, Garcia et al., 2011, Qi et al., 2009) (Table 2). 
 
What are the molecular components of triggered translocation mechanisms? 
Cytoskeletal proteins 
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Following transcription and translation, several mechanisms are thought to mediate AQP 
trafficking. AQPs may traffic within vesicles (Garcia et al., 2001), often via a microtubule 
network and sometimes with the involvement of the actin cytoskeleton, whereby re-
arrangement of the actin network assists in AQP membrane integration (Riethmuller et al., 
2008). Once fully integrated into the membrane, newly synthesised AQPs exhibit certain 
chemical properties. The most noticeable is the clustering of positively charged lysine and 
arginine residues at the cytoplasmic side of the channel, over the external region. This 
‘positive inside rule’ assists in facilitating insertion into the membrane (Lerch-Bader et al., 
2008).  
 
Elements of the mechanisms of post-translational translocation of AQPs may be different 
from constitutive AQP membrane expression mechanisms, although both actin and 
microtubules have been implicated in the regulation of the latter. Colchicine-induced 
disruption of microtubules suggested secretin-induced AQP1 translocation was mediated by 
the microtubule network (Marinelli et al., 1997). The microtubule network has been further 
implicated in the induced translocation of AQP1 from intracellular compartments to the cell 
membrane following diverse stimuli (Conner et al., 2010, Tietz et al., 2006). Studies have 
determined which proteins and mechanisms regulate AQP1 trafficking in cholangiocytes. 
Following addition of secretin or activation of messenger cAMP, AQP1 was shown to co-
localise with cytoskeletal motor proteins; dynein and kinesin in cholangiocytes. Partial 
reorganisation of actin upon vesicular contact at the apical membrane was thought to facilitate 
fusion with the cell membrane (Tietz et al., 2006). 
 
Similarly to studies on AQPs 1 and 2, inhibitors of the microtubule network and actin 
microfilaments implicated cytoskeletal proteins in the mechanism of AQP5 trafficking to the 
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plasma membrane (Tada et al., 1999). However, trafficking of AQP5 via microtubules (but 
not actin filaments) has been reported in Madin-Darby canine kidney cells (Karabasil et al., 
2009). Depolymerisation of the F-actin cytoskeleton using cytochalasin-D has also been 
shown to impair AQP4 plasma membrane localisation (Nicchia et al., 2008). Application of 
microtubule inhibitor colchicine was discovered to be sufficient to prevent cAMP stimulated 
translocation, emphasising reliance of AQP8 translocation on a fully functional microtubule 
network (Koyama et al., 1998). 
 
Calcium  
Calcium is ubiquitous in the mechanisms regulating cell signalling and function, so it is not 
surprising that calcium has been shown to be essential in the mechanism of translocation of 
AQPs. The role of calcium in trafficking of vesicles containing AQP5 has been demonstrated 
in human salivary gland cells in which thapsigargin and calcium ionophores induced AQP5 
trafficking (Ishikawa et al., 1998a). A putative calmodulin binding site at the N-terminus of 
AQP6 has also been identified (Rabaud et al., 2009). Calmodulin binding may have a role in 
the translocation of AQP6 to the cell surface; it is likely that trafficking of the majority of 
AQPs are stimulated by calcium elevations (Rabaud et al., 2009). 
Extracellular calcium influx and calmodulin have been shown to be involved in the 
hypotonicity-induced translocation of AQP1 to the plama membrane of human embryo kidey 
cells (HEK) and interestingly, there is a high degree of sequence homology between the 
AQP1 C-terminus and EF-hands from Ca2+-binding proteins belonging to the calmodulin 
superfamily (Fotiadis et al., 2002). 
 
Protein kinase A 
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Protein kinases are key regulators of vesicle and protein trafficking mechanisms (Pearce et 
al.). The involvement of PKA phosphorylation in the vasopressin-triggered translocation of 
AQP2 is well documented (Noda and Sasaki, 2006, Procino et al., 2003) and the AGC group 
of protein kinases is also involved in the regulation of other AQPs (Table 3). For example 
putative phosphorylation sites in the C-terminus of AQP0 have been implicated in membrane 
translocation. Studies involving oocyte swelling assays revealed that truncation of the AQP0 
C-terminus at residue 243 resulted in a 15% decrease in water permeability compared to full 
length AQP0, while surface protein expression analysis showed that impaired water 
permeability was a result of less efficient membrane trafficking. Truncation of the C-terminus 
at residue 234 or 238 resulted in completely impaired trafficking but interestingly, mutation of 
seine 235 to alanine had little effect on water permeability (Ball et al., 2003). Serine 235 in 
the C-terminus of AQP0 has been shown to be located in a PKA consensus sequence. Nuclear 
magnetic resonance data demonstrated that serine 235 phosphorylation resulted in inhibition 
of calmodulin binding to AQP0, and this calcium-dependent calmodulin binding to AQP0 
resulted in decreased membrane water permeability (Reichow and Gonen, 2008).  
 
AQP4 is particularly highly expressed in the astrocytic glial cells of the brain with a role in 
maintaining osmotic potential across the blood brain barrier (Pasantes-Morales and Cruz-
Rangel, 2010). Crucially, AQP4 knock-out models are protected from cytotoxic brain oedema 
(Manley et al., 2000) and AQP4 antibodies are thought to be key to the onset of neuromyelitis 
optica (Chan et al., 2012). Fluorescence localisation studies on histamine-mediated AQP4 
internalisation have shown AQP4 co-localisation with the mannose-6-phosphate receptor, a 
protein that assists in intracellular trafficking of lysosomal digestive enzymes from the Golgi 
sorting apparatus to the lysosome cell surface. During the internalisation period, AQP4 
underwent enhanced, specific phosphorylation via PKA; this was thought to be essential for 
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preventing redirection of AQP4 to the lysosomes. Removal of the stimulus enabled free 
AQP4 translocation from late endosomes back to the basolateral cell surface after a brief time 
delay (Carmosino et al., 2007). To confirm whether a vasopressin-triggered decrease in water 
permeability (Moeller et al., 2009) was due to alterations in a putative gating mechanism or 
endocytosis of the channel from the plasma membrane, measurements of capacitive currents 
were performed using a voltage-clamp technique on Xenopus oocytes. The gating possibility 
was rejected and verification of AQP4 endocytosis was obtained via immunoblotting in 
combination with immunofluorescence analyses. Contrary to the situation for AQP2, 
vasopressin was found not to mediate translocation of AQP4 from internal stores to the 
plasma membrane, but to induce internalisation of AQP4 from the cell surface. It was also 
discovered that vasopressin regulation could be mediated by protein kinase C (PKC), which 
phosphorylates serine 180 of loop D. This is believed to be the critical residue required for 
internalisation of AQP4. Interestingly, a second serine residue at position 111 was discovered 
which antagonised the actions of serine 180 as it serves to increase water permeability when 
activated by phosphorylation (Gunnarson et al., 2008). 
 
Using calcium ionophores to stimulate AQP5 plasma membrane localisation, it was deduced 
that activation of M3 muscarinic receptors by acetylcholine, leads to a signalling cascade 
occurring via intermediates, such as inositol 1,4,5-trisphosphate, triggering release of calcium 
from intracellular stores (Ishikawa et al., 1998b). Dephosphorylation of a PKA consensus 
sequence starting at serine residue 152 increased translocation of AQP5 to the membrane of 
Madin-Darby canine kidney cells (Karabasil et al., 2009). Although serine 156 of AQP5 has 
been shown to be phosphorylated in human bronchial epithelial cells, AQP5 targeting to the 
membrane may require additional mechanisms besides cAMP-dependent PKA 
phosphorylation (Woo et al., 2008). Constitutive membrane localisation of an AQP5-C-
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terminal GFP chimera in Madin-Darby canine kidney cells has also been observed, whereas 
an AQP5-N-terminal GFP chimera was localised in intracellular vesicles. Translocation of the 
AQP5-N-terminal GFP chimera in response to PKA activation was independent of 
phosphorylation of the putative PKA phosphorylation residue, threonine 259 (Kosugi-Tanaka 
et al., 2006). This suggests that the PKA phosphorylation of the C-terminus may not be 
involved in AQP5 translocation, however AQP5 has shown to be translocated to the plasma 
membrane in a PKA-dependent fashion in duodenal Brunner's gland tissue (Parvin et al., 
2005). The PKA pathway has also been shown to be involved in AQP5 regulation through 
cAMP induced AQP5 translocation to the plasma membrane of murine lung epithelial cells 
(Yang et al., 2003). 
 
AQP6 is thought to be retained within intracellular vesicles and recent studies have focused 
on identifying the mechanism and function of AQP6 retention in intracellular stores (Beitz et 
al., 2006). Localisation studies on AQP6-GFP chimeras have revealed that residues at the N-
terminal sequence of the protein are necessary and sufficient for cytosolic retention. 
Substitution of the N-terminal sequence on AQP1 for that of AQP6 resulted in intracellular 
retention of the AQP1/AQP6-N-terminus chimera. A putative AQP6 C-terminal PKA 
phosphorylation site was also identified but activation studies failed to demonstrate a 
significant role of this site in AQP6 localisation. Interestingly, continuous expression of 
AQP6 at the cell surface led to apoptosis of the cell (Beitz et al., 2006). 
 
AQP8 is expressed in a number of tissues but noted for its role in the colon (Liu et al., 2011). 
The expression and distribution of AQP8 in amnion epithelial cells were regulated by osmotic 
loads, suggesting a role for AQP8 in intramembranous water transport and the balance of 
amniotic fluid (Qi et al., 2009). AQP8 expression may also be stimulated to increase at the 
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cell surface by cAMP in hepatocytes; cells that normally exhibit low water permeability in 
their resting state due to intracellular sequestration of AQP8 (Garcia et al., 2001). Evidence 
for this was provided through labelling experiments, which showed an inverse correlation 
between AQP8 numbers located within microsomes and those on the plasma membrane, with 
an increase in the latter following stimulation by cAMP (Koyama et al., 1998). 
 
Although AQP8 shares conserved NPA sequences and 6 transmembrane architecture with 
other members of the aquaporin family (Koyama et al., 1998), it is interesting to note that 
despite cAMP-induced activation, AQP8 lacked the conserved regions required for 
phosphorylation via a PKA- or PKC-mediated mechanism. The significance of this points 
towards the possibility of an intermediate protein that is independent of the PKA pathway, 
being involved in phosphorylation of AQP8. 
 
Protein kinase C 
AQP1 was the first AQP identified (Agre et al., 1993) and has a diverse tissue distribution; 
including expression in red blood cells, kidney proximal tubule cells and the bile duct. Early 
studies suggested that AQP1 was constitutively expressed in cell membranes in the kidney 
(Knepper et al., 1996), however recent studies have shown that AQP1 is expressed in both the 
cytoplasm and in the membrane and can be induced to undergo rapid and reversible 
translocation to the plasma membrane upon hypotonic stimulation mediated by PKC and 
microtubules (Conner et al., 2010). This dynamic mechanism of AQP1 translocation in 
human embryo kidney cells involves extracellular calcium influx through stretch activated 
transient receptor potential channels and calmodulin-mediated PKC phosphorylation of two 
specific threonine residues at positions 157 and 239 (Conner et al., 2012). These residues of 
AQP1 have previously been shown to be phosphorylated by PKC. Furthermore, stimulation of 
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PKC resulted in an increase of AQP1-dependent water permeability and this was reduced in 
AQP1 mutants lacking either threonine 157 or threonine 239 and abolished in an AQP1 
mutant lacking both threonine residues (Zhang et al., 2007). 
 
AQP0 is the major protein in the membrane of the lens and has a role in cataract formation. 
Inhibition of PKC or mutation of serine 235 to alanine resulted in retention of AQP0, but not 
AQP1, in the cytoplasm suggesting that PKC phosphorylation of serine 235, following 
translation and ER/Golgi sorting, mediates specific AQP0 targeting to the cell surface 
(Golestaneh et al., 2008). 
 
The biochemical analysis of epinephrine-induced AQP3-translocation after 60 min in Caco-2 
colonic epithelia cells has been described. The use of inhibitors and activators for 
phospholipase C and PKC has suggested involvement of the PKC pathway (Yasui et al., 
2008). Threonine at position 514 in PKC was found to be phosphorylated with time upon the 
treatment of the cells with epinephrine while the phosphorylation of serine 660 in PKC was 
shown significantly following 60 min of the treatment. This suggests epinephrine mediated 
post-translational modification of PKC threonine 514 may act as a signal for translocation of 
AQP3 to the basolateral domain, and that perhaps phosphorylation of PKC serine 660 
activates the process of AQP3 recycling.  
 
AQP9 has greater sequence similarity to AQP3 and AQP7 than other AQPs and it has been 
suggested that in leukocytes AQP9 may be selective for water and urea but not glycerol 
(Ishibashi et al., 1998). It is thought to be involved in glycerol metabolism in the liver and 
adipocytes (Maeda et al., 2009). Potential AQP9 PKC binding or phosphorylation sites have 
been identified as serine residues 11 and 222 (Loitto et al., 2007). AQP9 has also been shown 
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to be phosphorylated in human neutrophils. Expression of AQP9 or a phosphomimetic 
mutation of the putative PKC phosphorylation site, serine 11, to aspartate dynamically 
localised to the plasma membrane and changed cell volume regulation as a response to 
hyperosmotic changes. However when serine 11 was mutated to alanine to create a 
phosphorylation deficient mutant, AQP9 failed to localise to the plasma membrane. AQP9 
translocation to the membrane was also shown to be regulated by the G protein Rac1 
(Karlsson et al., 2011). 
 
Protein kinase G 
The use of specific inhibitors has revealed that the mechanism of acetylcholine-induced 
AQP5 translocation is mediated by cGMP, calmodulin and protein kinase G (Ishikawa et al., 
2002). 
 
Phosphatidylinositol 3-kinase 
The aquaglyceroporin, AQP7, is responsible (with AQP3) for the majority of glycerol 
transport across the membranes of adipose tissue (Rodriguez et al., 2011a) and signalling 
pathways, including phosphatidylinositol 3-kinase, have been associated with the regulation 
of aquaglyceroporin transcription (Kishida et al., 2001). Evidence for negative feedback 
regulation in lipolytic states to restrict glycerol release from fat cells by restricting AQP7 
expression comes from treatment of cells with leptin, isoprenaline and carboxymethyl chitin 
(Rodriguez et al., 2011a). It is also thought that insulin regulates AQP7 levels, but the 
evidence is contradictory and there may be divergent effects of insulin on the regulation of all 
aquaglyceroporins in humans compared to rodents (Kishida et al., 2001, Rodriguez et al., 
2011b). Whilst it has been proposed that PKA may be involved in the translocation of AQP7 
(Kishida et al., 2000), experimental evidence for such a process is currently lacking. 
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Localisation and retention signals 
The AQP0 mouse model CatFr synthesises dysfunctional AQP0; AQP0-LTR in which LTR is 
translated into a peptide and causes retention of AQP0-LTR in sub-cellular compartments of 
lens epithelial cells producing cataracts (Kalman et al., 2006). 
 
AQP3 is a water/glycerol transporter, generally thought to be expressed in the basolateral 
membrane of cells. This has been demonstrated for the AQP3-rich, polarised epithelial 
(Zhang et al.) and kidney collecting duct cells (Langaa et al., 2012). Analysis of the AQP3 
protein sequence revealed the presence of a conserved localisation Tyr-Arg-Leu-Leu (YRLL) 
motif at the N-terminus. Mutations within this YRLL motif of either tyrosine or the di-leucine 
residues alone led to partial disruption of the protein translocation mechanism in vitro in 
polarised Madin-Darby canine kidney type II cells, whereas a complete mutation of the YRLL 
motif was presented with the complete absence of protein trafficking. The combined presence 
of the tyrosine, together with the di-leucine residues is essential for proper localisation at the 
basolateral domain (Rai et al., 2006). Chimeric proteins involving substitution of the AQP2 
N-terminus for that of the AQP3 was able to re-direct localisation of AQP2 from its original 
site at the apical membrane to its new site at the basolateral membrane. Interestingly, despite 
this clear amino acid-sorting motif, membrane expression of AQP3 is not polarised in red 
blood cells (Roudier et al., 1998) or in epidermal keratinocytes and in the epidermis “basal 
cells”; AQP3 may be predominantly intracellular (Sougrat et al., 2002). 
 
Systematic deletion analyses of C-terminal residues of AQP4 identified a region necessary for 
correct localisation of AQP4 in epithelial cells (Madrid et al., 2001). Two separate 
localisation signals have been identified within the C-terminal tail; a specific sequence 
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containing tyrosine 277 and its adjacent glycine residue was associated with correct 
localisation of AQP4 to the basolateral membrane. The second region consisted of a 
combined acidic cluster Glu-Thr-Glu-Asp (ETED) and a Leu-Ile-Leu (LIL) sequence motif, 
causing reduced localisation at the apical domain. The tyrosine sorting signal Try-Met-Glu-
Val (WMEV) doubles its function as a mediator of endocytosis via clathrin-coated vesicles. 
 
AQP11 and 12 appear to lack the conserved NPA motifs, being NPC and NPT in AQPs 11 
(Ikeda et al., 2010) and 12 (Itoh et al., 2005), respectively. Interestingly mutation of the 
alanine of the AQP4 NPA motif to threonine to mimic AQP12 resulted in retention within the 
endoplasmic reticulum of mammalian cell lines, whereas mutation of this alanine to cysteine, 
mimicking AQP11, expresses normally in plasma membrane (Guan et al., 2010). 
 
Conclusions: implications for disease therapies. 
Identification of the triggers and mechanisms of the dynamic regulation of AQP-containing 
vesicles from the cytoplasm to the membrane (Figure 2) is the focus of much interest. It is 
clear that the rapid, regulation of sub-cellular localisation of AQPs can be targeted to specific 
areas of the cell in order to increase water, ion or small molecule permeability. Manipulation 
of AQP abundance may therefore provide novel methods for treating specific diseases. For 
example, AQP4 knockout mice show an increased protection and reduced accumulation of 
water in the brain in models of ischemic stroke, cerebral injury and meningitis (Manley et al., 
2000, Papadopoulos and Verkman, 2005). The opposite is the case for hydrocephalus and 
vasogenic oedema, where AQP4 null mice show greater water accumulation in the brain and a 
worse clinical outcome (Papadopoulos et al., 2004). AQP5 is expressed in the ciliated 
epithelia that line the upper airways and is involved in near-isomolar fluid secretion by the 
epithelium of airway submucosal glands  (Verkman, 2003). Thus, the manipulation of AQP4 
19 
 
and AQP5 translocation and subsequent subcellular localisation appears to be a potential 
target for the development of novel drugs for cerebral oedema and cystic fibrosis (Song and 
Verkman, 2001, Zador et al., 2009). AQPs are an extremely important group of proteins and 
their role in diverse disease states is becoming more evident.  Identification of the stimuli and 
mechanisms of dynamic induced translocation may offer a new avenue for drug targets and 
eventual disease therapy.  
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Table 1: Tissue distribution and functional roles of the 13 human AQPs. The table summarises the 
distribution and function of AQPs in specific cells and tissues of the human body. 
Immunohistochemistry has revealed the diversity of AQP distribution within cells and tissues. For 
example, AQPs 1, 2, 3, 4, 6, 7, 8, 9, 10 and 11 have all been shown to be expressed in tissues of the 
kidney whereas AQP0 is almost exclusively expressed in lens epithelial cells. AQP11 expression in 
leucocytes may explain the immunohistochemical identification of AQP11 in other tissues. 
 
 
AQP Location Putative Functional Roles 
0 Lens fibre gap junctions Water regulation, structural function 
1 
Kidney (proximal renal tubule), eye, CNS, 
lung, erythrocytes 
Water homeostasis, fluid reabsorption 
2 Kidney collecting duct 
Water homeostasis, reabsorption from 
urine 
3 Kidney, epithelial cells 
Water homeostasis in renal collecting 
duct, glycerol/lipid metabolism 
4 
Glial cells, (astrocytes), renal collecting 
duct 
Water regulation, cerebral oedema 
5 Salivary glands, lung, eye Facilitates isotonic secretions 
6 Renal collecting duct Intracellular water/ion regulation 
7 Adipocytes, kidney, liver, testis Glycerol/lipid metabolism 
8 
Liver, kidney, testis, pancreas, heart, 
colon, placenta 
Water homeostasis 
9 
Kidney, liver, leucocytes, lung, spleen, 
brain, testis 
Water/ small molecule homeostasis, 
glycerol metabolism 
10 
Small intestine (duodenum, jejunum), 
kidney 
Water regulation 
11 
Kidney, testis, brain, pancreas, 
leucocytes, smooth muscle 
Unknown 
12 Pancreas Unknown 
Table 2: Triggers of aquaporin translocation to the plasma membrane (PM). The table 
summarises known stimuli of the dynamic translocation of AQPs, where possible avoiding 
observations solely linked to water permeability (WP) and/or transcription/translation. The 
experimental system used to determine the AQP translocation is included for each trigger. 
 
 
Trigger AQP Translocation Experimental system Reference 
Vasopressin 
AQP2 
AQP4 
PM 
WP 
Native kidney tissue 
Xenopus oocytes 
(Christensen et al., 2009) 
(Moeller et al., 2009) 
Histamine AQP4 PM Human gastric cells (Carmosino et al., 2007) 
Isoprenaline 
AQP3 
AQP7 
PM 
PM 
Human adipocytes 
Human adipocytes 
(Rodriguez et al., 2011b) 
(Rodriguez et al., 2011b) 
Secretin AQP1 PM Cholangiocytes (Marinelli et al., 1997) 
Vasoactive 
intestinal 
polypeptide 
AQP5 PM Duodenum (Brunner’s gland) (Parvin et al., 2005) 
Adrenaline 
AQP3 
AQP5 
PM 
PM 
Caco-2 epithelial cells 
Rat parotid cells 
(Yasui et al., 2008) 
(Ishikawa et al., 1999) 
Glutamate AQP4 PM/WP Astrocytes (Gunnarson et al., 2008) 
Acetylcholine AQP5 PM Rat parotid cells (Ishikawa et al., 1998b) 
Lipopolysaccharide AQP5 PM Lung epithelial cells (Ohinata et al., 2005) 
Hypotonicity 
AQP1 
AQP3 
AQP8 
PM 
PM 
PM 
HEK293/astrocytes 
Keratinocytes 
Amnion epithelial cells 
(Conner et al., 2010) 
(Garcia et al., 2011) 
(Qi et al., 2009) 
Hypertonicity 
AQP1 
AQP2 
AQP3 
AQP4 
AQP5 
AQP9 
PM 
PM 
PM 
PM 
PM 
PM 
Human neutrophils 
Collecting duct cells 
MDCK cells 
Rat astrocytes 
Lung epithelial cells 
Rat astrocytes 
(Loitto et al., 2007) 
(Hasler et al., 2005) 
(Matsuzaki et al., 2001) 
(Arima et al., 2003) 
(Hoffert et al., 2000) 
(Arima et al., 2003) 
Table 3. Intracellular components involved in the translocation of specific aquaporins to the 
plasma membrane (PM); The table summarises the components of dynamic translocation of AQPs 
avoiding, where possible, observations solely linked to water permeability (WP) and/or 
transcription/translation. Arrows indicate the direction of the effect. The experimental system used to 
determine the AQP translocation is included for each trigger and the residue that the component acts 
upon is also included where known. *AQP2 is not added in more detail than PKA-linked as this has 
been very well reviewed elsewhere (Valenti et al., 2005). 
 
Intracellular 
component 
AQP Effect Experimental system Residue Reference 
PKA 
AQP0 
AQP2* 
AQP4 
AQP5 
AQP5 
AQP6 
AQP7 
WP 
PM 
PM 
PM 
PM 
None 
Putative 
Collecting duct 
Kidney tissue 
Human gastric cells 
MDCK 
Brunner’s gland 
MDCK 
n/a 
S235 
S256 
- 
S152 
- 
- 
- 
(Reichow and Gonen, 2008) 
(Christensen et al., 2000) 
(Carmosino et al., 2007) 
(Karabasil et al., 2009) 
(Parvin et al., 2005) 
(Beitz et al., 2006) 
(Kishida et al., 2000) 
PKC 
AQP0 
AQP1 
AQP3 
AQP3 
AQP4 
AQP4 
AQP91 
PM 
PM 
PM 
PM 
PM 
PM 
PM 
RK13 epithelial cells 
HEK293 cells 
Caco-2 epithelial cells 
Caco-2 epithelial cells 
Astrocytes 
Xenopus oocytes 
Human neutrophils 
S235 
T157/T239 
T514 
S660 
S111 
S180 
S11/S222 
(Golestaneh et al., 2008) 
(Conner et al., 2012) 
(Yasui et al., 2008) 
(Yasui et al., 2008) 
(Gunnarson et al., 2008) 
(Moeller et al., 2009) 
(Karlsson et al., 2011) 
PKG AQP5 PM Rat parotid cells - (Ishikawa et al., 2002) 
Actin 
AQP1 
AQP4 
AQP5 
AQP5 
PM 
PM 
PM 
PM 
Cholangiocytes 
Astrocytes 
Salivary gland cells 
Rat parotid 
- 
- 
- 
- 
(Tietz et al., 2006) 
(Nicchia et al., 2008) 
(Tada et al., 1999) 
(Ishikawa et al., 1999) 
Microtubule 
 
+ cAMP 
AQP1 
AQP5 
AQP8 
AQP5 
PM 
PM 
PM 
PM 
HEK293 cells 
MDCK cells 
Hepatocytes 
Lung epithelial cells 
- 
- 
- 
- 
(Conner et al., 2010) 
(Karabasil et al., 2009) 
(Garcia et al., 2001) 
(Yang et al., 2003) 
Ca2+/ 
Calmodulin 
AQP1 
AQP5 
AQP6 
PM 
PM 
PM 
HEK293 cells 
Rat parotid cells 
CHO-K1 cells 
- 
- 
- 
(Conner et al., 2012) 
(Ishikawa et al., 1998a, 
Ishikawa et al., 1999, 
Rabaud et al., 2009) 
TRP channels AQP1 PM HEK293 cells - (Conner et al., 2012) 
RAC1 AQP9 PM Human neutrophils - (Karlsson et al., 2011) 
Dynein AQP1 PM Cholangiocytes - (Marinelli et al., 1997) 
Kinesin AQP1 PM Cholangiocytes - (Marinelli et al., 1997) 
 Figure 1: Schematic diagram of the shared structural architecture of 
aquaporins. Six transmembrane α-helices are connected by alternating extracellular 
and intracellular loops with the carboxyl and amino termini orientated towards the 
cytoplasm. Two of these connecting loops (B and E) fold into the transmembrane pore 
each forming a helical region containing highly conserved Asn-Pro-Ala (NPA) motifs 
that facilitate selectivity of the pore.  
 
Figure 2: Trigger-induced aquaporin translocation: a regulatory mechanism for 
cellular water flow. Some or all of the components shown may be involved in the 
translocation of different AQPs. For example, AQP1 translocation is known to be 
triggered by hypotonicity, which causes calcium influx through transient receptor 
potential (TRP) channels and subsequent calmodulinmediated PKC phosphorylation 
of specific AQP1 threonine residues, resulting in microtubule-dependent AQP1 
translocation. Other protein kinases are thought to be involved in AQP translocation 
such as PKAmediated translocation of AQP2 and AQP5 following activation of 
vasopressin V2 and M3 muscarinic GPCRs, respectively. 
 


